Advertisement
News
Subscribe to MDT Magazine News

Health insurer stocks rise after HHS announcement

November 22, 2010 9:46 am | by TOM MURPHY - AP Business Writer - Associated Press | Comments

Several large health insurance stocks climbed Monday while the broader market fell after the Obama administration announced details of a new rule that will govern how much insurers spend on medical care.Starting next year, insurers will have to spend at least 80 cents of the premium dollar on...

Celldex advances brain tumor vaccine

November 22, 2010 9:36 am | by Mass High Tech: The Journal of New England Technology | Comments

Celldex Therapeutics Inc. said its therapeutic vaccine to treat the most common and most aggressive form of brain tumor has been successful in temporarily halting the progression of the disease for about two-thirds of the patients in a Phase 2 study.

TOPICS:

Military experts provide civilian surgeons with guidance on handling bomb blast injuries

November 22, 2010 9:34 am | by EurekAlert | Comments

(Wiley-Blackwell) "The recent international security alerts provide a timely reminder that surgeons could be called on at a moment's notice to deal with blast injuries" says consultant surgeon Jonothan Earnshaw, joint editor-in-chief of BJS, the British Journal of Surgery. BJS has just...

TOPICS:
Advertisement

Earnings Preview: Medtronic to report 2Q earnings

November 22, 2010 7:46 am | by The Associated Press | Comments

Medtronic Inc., the world's largest medical device maker, announces its fiscal second-quarter earnings Tuesday morning before markets open.WHAT TO WATCH FOR: Last quarter the company reported a sharp drop in sales of pacemakers, stents and other medical implants. The company said the shortfall...

Archemix sells hemophilia drug assets to Baxter for up to $305M

November 22, 2010 5:37 am | by Mass High Tech: The Journal of New England Technology | Comments

Cambridge-based Archemix Corp. has agreed to sell all of its hemophilia-related assets to Illinois life sciences company Baxter International Inc. for a deal that could be worth up to $305 million for Archemix.

IBM Powers Russian Pharmaceutical Company PROTEK

November 22, 2010 5:34 am | by IBM | Comments

IBM today announced that Russian pharmaceutical distributor PROTEK has switched to IBM POWER7 systems for its data processing center. The new systems from IBM replace the previous servers from HP, enabling PROTEK to improve the performance of critical business applications while reducing...

TOPICS:

ACT gets OK for embryonic stem cell-based trial

November 22, 2010 5:33 am | by Mass High Tech: The Journal of New England Technology | Comments

Worcester biotech Advanced Cell Technology Inc. has received clearance from the U.S. Food and Drug Administration to launch a Phase 1/2 clinical trial using retinal cells based on human embryonic stem cells.

TOPICS:

Humana to purchase health care company Concentra

November 22, 2010 4:45 am | by The Associated Press | Comments

Health insurer Humana Inc. says it plans to purchase Texas-based health care company Concentra Inc. in an approximately $790 million cash deal.Humana Chairman and CEO Michael B. McCallister said Monday that the acquisition will reinforce Humana's core business while diversifying revenue and...

Advertisement

Feds OK 2nd human study of embryonic stem cells

November 21, 2010 7:45 pm | by MALCOLM RITTER - AP Science Writer - Associated Press | Comments

For only the second time, the U.S. government has approved a test in people of a treatment using embryonic stem cells — this time for a rare disease that causes serious vision loss.Advanced Cell Technology, a biotechnology company based in Santa Monica., Calif., said the research should begin...

Genes link puberty timing and body fat in women

November 21, 2010 10:34 am | by EurekAlert | Comments

(Boston University Medical Center) Scientists have discovered 30 new genes that control the age of sexual maturation in women. Notably, many of these genes also act on body weight regulation or biological pathways related to fat metabolism. The study, which appears in Nature...

TOPICS:

Gene linked to worsening kidney disease in African-Americans

November 20, 2010 4:34 pm | by EurekAlert | Comments

(American Society of Nephrology) In African-Americans with kidney disease related to hypertension (high blood pressure), a common gene variant is associated with a sharply increased risk of progressive kidney disease, according to a study presented at the American Society of Nephrology's...

TOPICS:

Celldex: Positive results for brain cancer drug(2)

November 20, 2010 10:46 am | by The Associated Press | Comments

Cancer drug developer Celldex Therapeutics Inc. said on Saturday that one of its drugs extended survival in a trial of 65 brain cancer patients.The company's injectable CDX-110 is designed to treat glioblastoma, the most common and aggressive type of brain cancer.It said the most recent study...

Celldex: Positive results for brain cancer drug

November 20, 2010 10:45 am | Comments

Cancer drug developer Celldex Therapeutics Inc. said on Saturday that one of its drugs extended survival in a trial of 65 brain cancer patients.The company's injectable CDX-110 is designed to treat glioblastoma, the most common and aggressive type of brain cancer.It said the most recent study...

Baxter: Sigma & #8217;s Pump Recall Won & #8217;t Derail Transition Plan

November 19, 2010 12:38 pm | by U.S. Food & Drug Administration | Comments

Despite a Class I recall of Sigma’s Spectrum infusion pumps, Baxter Healthcare will continue to transition customers from its Colleague pump to the Spectrum model.

Disagreements Should Be Voiced Before FDA Investigator Leaves

November 19, 2010 12:37 pm | by U.S. Food & Drug Administration | Comments

Manufacturers that disagree with inspection observations should make sure they bring it up before an investigator walks out the door, a former FDA official says.

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading